BrainAurora Medical Technology Limited (HKG:6681)
Hong Kong · Delayed Price · Currency is HKD 0.8750
-0.0850 (-8.85%)
Oct 23, 2026, 4:08 PM HKT
HKG:6681 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 239.88 | 220.05 | 122.31 | 67.2 | 11.29 | 2.3 |
Revenue Growth | 9.01% | 79.91% | 82.01% | 495.16% | 391.13% | - |
Gross Profit Gross Profit Growth | 103.22 | 89.45 | 54.01 | 32.06 | 3.3 | 1.3 |
Operating Income Operating Income Growth | -281.01 | -290.95 | -184.83 | -146.78 | -104.07 | -69.06 |
Net Income Net Income Growth | -322.5 | -314.86 | -198.28 | -359.08 | -502.45 | -697.84 |
Earnings Per Share EPS Growth | -0.26 | -0.27 | -0.23 | -0.62 | -1.79 | -4.64 |
EPS Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Provision of The System Integral Software Solutions Provision of The System Integral Software Solutions Growth | 187.46 | 167.23 | 106.11 | 46.95 | 5.17 | 1.21 |
Research Projects Research Projects Growth | 4.48 | 2.13 | 15.94 | 14.29 | 5.99 | 0.41 |
Medical Artificial Intelligence ("ai") Large Language Model Solutions Medical Artificial Intelligence ("ai") Large Language Model Solutions Growth | 46.59 | 49.78 | - | - | - | - |
Others Others Growth | 1.35 | 0.91 | 0.26 | 0.88 | 0.13 | 0.68 |
Total Total Growth | 239.88 | 220.05 | 122.31 | 67.2 | 11.29 | 2.3 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 658.44 | 430.36 | 343.88 | 57.58 | 287.22 | 323.74 |
Total Debt Total Debt Growth | 556.24 | 565.52 | 994.68 | 679.62 | 330.5 | 464.59 |
Net Cash (Debt) Net Cash Growth | 102.2 | -135.16 | -650.8 | -622.04 | -43.28 | -140.85 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 0.08 | -0.11 | -0.65 | -1.07 | -0.15 | -0.94 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -206.5 | -178.03 | -146.04 | -136.87 | -100.68 | -49.21 |
Capital Expenditures CapEx Growth | -24.13 | -14.31 | -17.33 | -15.97 | -16.4 | -10.8 |
Free Cash Flow Free Cash Flow Growth | -230.63 | -192.34 | -163.37 | -152.84 | -117.08 | -60.01 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 43.03% | 40.65% | 44.16% | 47.71% | 29.20% | 56.72% |
Operating Margin | -117.14% | -132.22% | -151.12% | -218.43% | -921.71% | -3004.09% |
Pretax Margin | -135.73% | -143.72% | -162.34% | -534.40% | -4450.10% | -30353.98% |
Profit Margin | -134.44% | -143.09% | -162.11% | -534.35% | -4450.02% | -30353.94% |
FCF Margin | -96.14% | -87.41% | -133.57% | -227.44% | -1036.94% | -2610.05% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PS Ratio | 4.29 | 33.30 | - | - | - | - |